ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Clinical trials for ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) explained in plain language.
Never miss a new study
Get alerted when new ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) trials appear
Sign up with your email to follow new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New ADHD pill tested for Year-Long safety in kids
Disease control Recruiting nowThis study tests the safety of a daily medication called EB-1020 for children and teenagers with ADHD over 52 weeks. About 180 participants in Japan and China will take the drug once a day. Researchers will monitor side effects to see if long-term use is safe.
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New ADHD pill for kids tested in Japan-China joint trial
Symptom relief Recruiting nowThis study tests whether a once-daily capsule called EB-1020 can safely reduce ADHD symptoms in children and adolescents aged 6 to 17. About 315 participants will receive either a low dose, a high dose, or a placebo for 6 weeks. The main goal is to see if symptoms improve using a…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE2, PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Could a common ADHD drug also lift depression? new trial investigates
Symptom relief Recruiting nowThis study tests whether two different forms of dexamphetamine (a stimulant) can safely help adults who have both ADHD and moderate to severe depression. About 105 participants will receive either the drug or a placebo. The main goal is to check for side effects and see if the tr…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE2 • Sponsor: Prof. Dr. Frank Behrens • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC
-
Can tea compounds sharpen focus in ADHD and autism? new study investigates.
Symptom relief Recruiting nowThis pilot study tests whether a combination of two natural compounds, L-theanine and paraxanthine, can temporarily improve attention, self-control, and thinking in adults with ADHD or autism. About 24 participants will take the supplement or a placebo and then complete brain sca…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: NA • Sponsor: Texas Tech University Health Sciences Center • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC
-
Brain scans reveal how ADHD meds work in kids with autism
Symptom relief Recruiting nowThis study looks at whether Adderall XR (a common ADHD medication) can reduce ADHD symptoms in children and teens with autism who have normal language skills. About 196 participants will receive either the drug or a placebo for 4 weeks. Researchers will also use brain scans to se…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE4 • Sponsor: Gagan Joshi • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC
-
Video games as medicine? new study tests Brain-Controlled therapy for ADHD kids
Symptom relief Recruiting nowThis study explores whether playing special brain-controlled games at home can help school-aged children (ages 7 to 11) with mild to moderate ADHD improve their attention and reduce hyperactivity. About 146 children will be randomly assigned to either the game therapy or a contro…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: NA • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC
-
Could a common ADHD drug sharpen focus in kids with sickle cell disease?
Symptom relief Recruiting nowThis study tests whether children with sickle cell disease (SCD) can safely take a daily stimulant drug called methylphenidate for 4 weeks to improve attention, thinking, and schoolwork. About 72 children ages 8 to 17 with SCD and thinking or attention problems will take the drug…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated May 06, 2026 16:01 UTC
-
VR driving game aims to cut ADHD teen crashes
Symptom relief Recruiting nowThis study tests whether a virtual reality driving program can teach teens with ADHD to keep their eyes on the road. About 200 teens aged 16-19 with ADHD will practice driving in a simulator while doing distracting tasks, like looking at a GPS. The goal is to reduce dangerous gla…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated May 05, 2026 11:53 UTC
-
Wearable tech reveals hidden links between sleep, exercise, and ADHD
Knowledge-focused Recruiting nowThis study looks at how sleep, physical activity, and daily body rhythms are connected to ADHD symptoms in children. Researchers will use a wristband to track activity and sleep for two weeks, along with brain scans and thinking tests. The goal is to better understand why ADHD af…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: NA • Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 03:10 UTC
-
Can your DNA predict ADHD drug success?
Knowledge-focused Recruiting nowThis study explores how a child's genetic makeup influences their response to methylphenidate, a common ADHD medication. Researchers will track symptom changes and side effects in 400 participants aged 6 to 24 across Western Canada. The goal is to find genetic markers that could …
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Sponsor: University of Calgary • Aim: Knowledge-focused
Last updated May 06, 2026 16:14 UTC
-
Your Child's footprint might reveal ADHD risk, new study suggests
Knowledge-focused Recruiting nowThis study explores whether how kids stand and walk can help predict ADHD. Researchers will measure foot pressure and posture in 100 middle school students, some with ADHD symptoms and some without. They will use machine learning to see if these physical measurements can identify…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Sponsor: Biruni University • Aim: Knowledge-focused
Last updated May 05, 2026 11:55 UTC